OUP Management as of Sept. 30, 2022
Portfolio Holdings for OUP Management
OUP Management holds 15 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 18.4 | $12M | 2.9M | 4.02 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 18.3 | $12M | 989k | 11.90 | |
| DICE Therapeutics Common Stock | 16.9 | $11M | 537k | 20.28 | |
| Aerovate Therapeutics Common Stock (AVTE) | 15.6 | $10M | 604k | 16.58 | |
| ionQ Common Stock (IONQ) | 9.3 | $6.0M | 1.2M | 5.07 | |
| Cyteir Therapeutics Common Stock | 7.4 | $4.7M | 2.5M | 1.92 | |
| Vor Biopharma Common Stock (VOR) | 2.3 | $1.5M | 375k | 3.98 | |
| Precision BioSciences Common Stock | 2.3 | $1.5M | 1.1M | 1.30 | |
| Selecta Biosciences Common Stock | 2.2 | $1.4M | 863k | 1.64 | |
| Evolv Technologies Holdings Common Stock (EVLV) | 2.2 | $1.4M | 653k | 2.12 | |
| Graphite Bio Common Stock | 2.0 | $1.3M | 406k | 3.17 | |
| Landos Biopharma Common Stock | 1.3 | $804k | 1.2M | 0.65 | |
| eFFECTOR Therapeutics Common Stock | 0.9 | $587k | 1.0M | 0.57 | |
| Spero Therapeutics Common Stock (SPRO) | 0.8 | $498k | 249k | 2.00 | |
| Homology Medicines Common Stock | 0.2 | $103k | 64k | 1.61 |
